Question 1

How does Travoprost compare to my current eye drops?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) clinical trial (NCT00762645). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of Travoprost and Pilocarpine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) clinical trial (NCT00762645). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my eye pressure be monitored during treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) clinical trial (NCT00762645). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I experience any discomfort while using these drops?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) clinical trial (NCT00762645). Contact the study team or your healthcare provider for specific answers.

Question 5

Am I eligible for this trial based on my current eye condition and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) clinical trial (NCT00762645). Contact the study team or your healthcare provider for specific answers.

What this study is about